n-benzylglucamine dithiocarbamate has been researched along with Hepatolenticular Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamura, Y; Kiyozumi, M; Okawara, T; Shimada, A; Shimada, H; Takahashi, M; Yasutake, A | 1 |
1 other study(ies) available for n-benzylglucamine dithiocarbamate and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Protection from spontaneous hepatocellular damage by N-benzyl-d-glucamine dithiocarbamate in Long-Evans Cinnamon rats, an animal model of Wilson's disease.
Topics: Animals; Body Weight; Chelating Agents; Copper; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hepatolenticular Degeneration; Humans; Liver; Rats; Rats, Long-Evans; Sorbitol; Thiocarbamates | 2005 |